Prognostic Value of SLC16A3(MCT4) in Lung Adenocarcinoma and Its Clinical Significance
Lei Xue,1,* Jinyuan Liu,1,* Jiaheng Xie,2,* Jinhua Luo1 1Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, People’s Republic of China; 2Department of Burn and Plastic Surgery, The First Affiliated Hospital o...
Guardado en:
Autores principales: | Xue L, Liu J, Xie J, Luo J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ff0717d4d904d489e3635eb15df114a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Weihao Lin, et al.
Publicado: (2021) -
GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Jiahui Han, et al.
Publicado: (2021) -
Iron homeostasis in the lung
por: GHIO,ANDREW J, et al.
Publicado: (2006) -
Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression
por: Liu Z, et al.
Publicado: (2021) -
Adenocarcinoma lung presenting with meningeal carcinomatosis
por: Ramakant Dixit, et al.
Publicado: (2021)